Copyright
©The Author(s) 2019.
World J Diabetes. Apr 15, 2019; 10(4): 249-259
Published online Apr 15, 2019. doi: 10.4239/wjd.v10.i4.249
Published online Apr 15, 2019. doi: 10.4239/wjd.v10.i4.249
Table 3 Screening of diabetes-related complications in patients with diabetes mellitus
Screening for any diabetes-related complication, n (%) | |
Yes | 553 (97.9) |
No | 12 (2.1) |
Screening for cardiovascular disease | |
At least one time during the past year | 376 (76.9) |
Never | 113 (23.1) |
Eye screening | |
At least one time during the past year | 295 (65.7) |
Never | 154 (34.3) |
Number of eye screening, mean (SD) | 1.20 (0.57) |
Screening for nerve damage | |
At least one time during the past year | 232 (53.8) |
Never | 199 (46.2) |
Number of screening for nerve damage, mean ± SD | 1.75 ± 1.01 |
Screening for kidney damage | |
At least one time during the past year | 425 (82.5) |
Never | 90 (17.5) |
Number of screening for kidney damage, mean ± SD | 1.87 ± 1.02 |
Screening for foot examination | |
At least one time during the past year | 297 (63.9) |
Never | 168 (36.1) |
Number of screening for foot examination, mean ± SD | 1.90 ± 1.08 |
Screening for blood lipid control | |
At least one time during the past year | 496 (94.8) |
Never | 27 (5.2) |
Number of screening for blood lipid control, mean ± SD | 2.06 ± 1.04 |
Screening for blood pressure control n (%) | |
At least one time during the past year | 286 (86.1) |
Never | 46 (13.9) |
Number of screening for blood pressure control, mean ± SD | 2.57 ± 1.17 |
- Citation: Ahmadieh H, Sawaya MT, Azar ST. Management and control of type 2 diabetes mellitus in Lebanon: Results from the International Diabetes Management Practices Study Wave 6. World J Diabetes 2019; 10(4): 249-259
- URL: https://www.wjgnet.com/1948-9358/full/v10/i4/249.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i4.249